Companies Scramble for CBD Patents, Igniting Fear of Corporate Cannabis

Things are moving fast in the international pharmaceutical industry’s push to turn the chemicals behind the remarkable properties of the cannabis plant into trademarked products. Unsurprisingly, a special emphasis is on cannabidiol, or CBD—a compound with wide-ranging medical potentials still being uncovered. This May alone, several patents and intellectual property agreements were sought or secured…